company background image
SLGC

SomaLogic NasdaqGM:SLGC Stock Report

Last Price

US$2.72

Market Cap

US$510.1m

7D

-3.5%

1Y

-77.9%

Updated

08 Dec, 2022

Data

Company Financials +
SLGC fundamental analysis
Snowflake Score
Valuation1/6
Future Growth2/6
Past Performance0/6
Financial Health6/6
Dividends0/6

SLGC Stock Overview

SomaLogic, Inc. operates as a protein biomarker discovery and clinical diagnostics company in the United States.

SomaLogic, Inc. Competitors

Price History & Performance

Summary of all time highs, changes and price drops for SomaLogic
Historical stock prices
Current Share PriceUS$2.72
52 Week HighUS$13.25
52 Week LowUS$2.58
Beta0
1 Month Change-1.09%
3 Month Change-31.66%
1 Year Change-77.92%
3 Year Changen/a
5 Year Changen/a
Change since IPOn/a

Recent News & Updates

Recent updates

We're Hopeful That SomaLogic (NASDAQ:SLGC) Will Use Its Cash Wisely

Jun 06
We're Hopeful That SomaLogic (NASDAQ:SLGC) Will Use Its Cash Wisely

Calculating The Intrinsic Value Of SomaLogic, Inc. (NASDAQ:SLGC)

Mar 09
Calculating The Intrinsic Value Of SomaLogic, Inc. (NASDAQ:SLGC)

We Think SomaLogic (NASDAQ:SLGC) Can Easily Afford To Drive Business Growth

Dec 28
We Think SomaLogic (NASDAQ:SLGC) Can Easily Afford To Drive Business Growth

Shareholder Returns

SLGCUS Life SciencesUS Market
7D-3.5%-2.1%-3.7%
1Y-77.9%-29.0%-21.2%

Return vs Industry: SLGC underperformed the US Life Sciences industry which returned -29% over the past year.

Return vs Market: SLGC underperformed the US Market which returned -21.2% over the past year.

Price Volatility

Is SLGC's price volatile compared to industry and market?
SLGC volatility
SLGC Average Weekly Movement11.1%
Life Sciences Industry Average Movement11.4%
Market Average Movement7.4%
10% most volatile stocks in US Market15.6%
10% least volatile stocks in US Market3.3%

Stable Share Price: SLGC is more volatile than 75% of US stocks over the past 3 months, typically moving +/- 11% a week.

Volatility Over Time: SLGC's weekly volatility (11%) has been stable over the past year, but is still higher than 75% of US stocks.

About the Company

FoundedEmployeesCEOWebsite
1999320Roy Smythehttps://www.somalogic.com

SomaLogic, Inc. operates as a protein biomarker discovery and clinical diagnostics company in the United States. It develops slow off-rate modified aptamers (SOMAmers), which are modified nucleic acid-based protein binding reagents that are specific for their cognate protein; and offers proprietary SomaScan services, which provide multiplex protein detection and quantification of protein levels in complex biological samples. The company’s SOMAmers/SomaScan technology enables researchers to analyze various types of biological samples for protein biomarker signatures, which can be utilized in drug discovery and development.

SomaLogic, Inc. Fundamentals Summary

How do SomaLogic's earnings and revenue compare to its market cap?
SLGC fundamental statistics
Market CapUS$510.07m
Earnings (TTM)-US$83.21m
Revenue (TTM)US$101.83m

5.0x

P/S Ratio

-6.1x

P/E Ratio

Earnings & Revenue

Key profitability statistics from the latest earnings report
SLGC income statement (TTM)
RevenueUS$101.83m
Cost of RevenueUS$96.45m
Gross ProfitUS$5.38m
Other ExpensesUS$88.60m
Earnings-US$83.21m

Last Reported Earnings

Sep 30, 2022

Next Earnings Date

n/a

Earnings per share (EPS)-0.44
Gross Margin5.29%
Net Profit Margin-81.72%
Debt/Equity Ratio0%

How did SLGC perform over the long term?

See historical performance and comparison